Reducing CDK4/6-p16(INK4a) interface. Computational alanine scanning of a peptide bound to CDK6 protein

Oscar Villacañas1, Jaime Rubio-Martinez

  • 1Departament de Química Física, Universitat de Barcelona, Martí i Franquès 1, E-08028 Barcelona, Spain.

Proteins
|March 2, 2006
PubMed

Insights

Researchers modeled the theoretical structure of a p16INK4a peptide bound to CDK6, a protein involved in cell cycle arrest. This structure, refined with solvation effects, aids understanding of cancer suppressor mechanisms.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • The p16INK4a tumor suppressor gene is frequently altered in various cancers.
  • Its encoded protein inhibits cell cycle progression by binding to CDK4 and CDK6.
  • A p16INK4a-derived peptide retains cell cycle inhibition but lacks a determined structure.

Purpose of the Study:

  • To report the features of a theoretical structure of the p16INK4a peptide bound to CDK6.
  • To provide insights into the molecular mechanisms of cell cycle inhibition by the peptide.

Main Methods:

  • Modeling of the p16INK4a peptide-CDK6 complex using X-ray crystallography data.
  • Molecular dynamics simulations to refine the complex structure.
  • Assessment of the theoretical structure by comparing computed binding free energy changes with experimental data from single-alanine substitutions.

Main Results:

  • A theoretical structure of the p16INK4a peptide bound to CDK6 was successfully modeled.
  • Inclusion of high-level solvation effects, including solute-solvent van der Waals and electrostatic energies, significantly improved concordance between computed and experimental data.
  • The study highlights the importance of solvation in accurately predicting protein-peptide interactions.

Conclusions:

  • The reported theoretical structure provides a basis for understanding the interaction between the p16INK4a peptide and CDK6.
  • Accurate structural modeling of such complexes requires careful consideration of solvation effects.
  • This work contributes to the development of strategies targeting cell cycle regulation in cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...